India's Pharma Export Surge: A $130 Billion Future

India's pharmaceutical exports reached over USD 28 billion, marking over 5% growth despite global challenges. Projected to grow to USD 130 billion by 2030, the sector focuses on policy prioritization, market diversification, increased FDI, and regulatory improvements, with significant exports to the US and Europe.

India's pharmaceutical exports exceeded USD 28 billion up to February this financial year, registering growth of over 5% compared to the previous year, according to a top official.

K Raja Bhanu, Director General of Pharmexcil, highlighted the sector's current valuation at USD 60 billion, with projections to reach USD 130 billion by 2030.

Pharmaceutical exports, driven by formulations, biologicals, vaccines, and AYUSH products, achieved USD 28.29 billion in April–February FY26, reflecting a 5.6% increase over the same period in FY25, despite global pricing pressures and volatility.

(With inputs from agencies.)